Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Green Power Group Forms Electric-Truck Battery Joint Venture With Oscar Investama Indonesia

Green Power Group Forms Electric-Truck Battery Joint Venture With Oscar Investama Indonesia

BitgetBitget2026/10/19 15:29
  • Green Power Group formed electric-truck battery joint venture Gobattery Solusi Indonesia with Oscar Investama Indonesia on October 13, 2026.
  • The venture has Rp 10 billion in authorized capital; Green Power holds 51%, with Oscar Investama owning 49%.
  • Gobattery will own and manage batteries under a battery-as-a-service model, charging fleet operators recurring rental fees.
  • Oscarmas' sales and after-sales network will support access to fleet operators.
  • Operations will begin in phases on selected logistics routes once business permits are secured.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PT Green Power Group Tbk published the original content used to generate this news brief via Indonesia Stock Exchange (IDX) (Ref. ID: 32167566) on October 19, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12